PROM1 and neoplasm: In pilot experiments, we utilized a magnetic bead based separation method to generate tumor-derived cell populations enriched for CD133+ or CD133- cells, which were then injected into NOD/SCID mice to assess the relative tumorigenicity of each fraction.